天弘国证生物医药ETF发起式联接A(011040)资产配置
序号 |
报告期 |
股票占净比(%) |
债券占净比(%) |
现金占净比(%) |
净资产(元) |
1 |
2024-12-31 |
2.46 |
- |
5.70 |
1,110,355,939.42 |
2 |
2024-09-30 |
0.41 |
0.47 |
4.84 |
1,194,699,249.48 |
3 |
2024-06-30 |
4.08 |
- |
5.59 |
999,945,413.27 |
4 |
2024-03-31 |
4.23 |
0.12 |
5.42 |
1,034,152,806.47 |
5 |
2023-12-31 |
4.50 |
0.13 |
5.15 |
1,208,366,592.07 |
6 |
2023-09-30 |
2.02 |
0.09 |
5.17 |
1,257,759,616.86 |
7 |
2023-06-30 |
3.66 |
0.10 |
5.31 |
1,226,168,824.64 |
8 |
2023-03-31 |
3.49 |
- |
5.72 |
1,063,401,641.10 |
9 |
2022-12-31 |
1.40 |
0.02 |
5.48 |
1,041,581,113.46 |
10 |
2022-09-30 |
0.99 |
- |
5.55 |
1,072,115,424.90 |
11 |
2022-06-30 |
2.83 |
- |
5.55 |
1,020,049,622.21 |
12 |
2022-03-31 |
2.22 |
- |
5.73 |
912,941,655.19 |
13 |
2021-12-31 |
3.51 |
- |
5.55 |
1,046,599,200.56 |
14 |
2021-09-30 |
94.33 |
- |
5.68 |
689,589,518.81 |
15 |
2021-06-30 |
95.73 |
0.05 |
6.37 |
639,924,933.01 |
16 |
2021-03-31 |
94.78 |
- |
6.29 |
385,654,315.34 |